犬脓皮症与耐药菌：为什么"抹点药膏"总复发
2026/10/3· 约 4 分钟读完· 22 个要点
脓皮症几乎总是"继发"于过敏、寄生虫或内分泌问题，只杀菌不处理原发病必然复发。这篇按系统综述与耐药风险研究，讲清疗程、药浴与根源管理。
一、先认清：脓皮症是结果，不是原因
犬浅层脓皮症的典型表现：
- 圆形脱毛斑、红疹、脓疱、结痂、皮屑；
- 瘙痒程度不一（有些并不太痒）；
- 常见于腹部、腋下、趾间、皮肤褶皱处。
关键认知：细菌性皮肤感染通常继发于过敏（跳蚤/食物/特应性皮炎）、寄生虫、内分泌疾病或皮肤屏障问题。系统综述对全身性抗菌治疗在浅层/深层脓皮症中的效果给出了评价[1]——有效，但不处理原发病就会反复。
三、耐药性不是抽象概念
2022 年一项研究分析了脓皮症犬与其主人分离葡萄球菌的耐药风险因素[2]——提示耐药菌在"患病犬—家庭环境"之间存在关联，这直接支撑两件事：
- 不要自行用/停抗生素，也不要使用上次剩下的药；
- 按兽医建议做细菌培养 + 药敏试验（尤其反复发作或治疗无效的病例）。
科研依据与原文（可直接查看）
下列每条都是本文引用的同行评议文献，本站已把原文摘要抓下来，点「展开原文摘要」即可在站内阅读； 需要看全文时可点 PubMed / Europe PMC / DOI 任一入口（多条备选，避免单点打不开）。
- 1
The effectiveness of systemic antimicrobial treatment in canine superficial and deep pyoderma: a systematic review
Summers JF, Brodbelt DC, Forsythe PJ, Loeffler A 等 · Veterinary dermatology · 2012
👉 系统评价全身抗菌治疗的效果边界，支撑"疗程足够+处理原发病"。
展开原文摘要（英文，2044 字）
To identify and evaluate existing evidence for the effectiveness of systemic antimicrobial treatments for naturally occurring superficial and deep canine pyoderma. Electronic searches of PubMed, MEDLINE and CAB Direct were carried out (25 May 2011) without date or language restrictions. Proceedings of ESVD/ECVD, AAVD/ACVD, NAVDF and WCVD annual congresses were searched. Unpublished studies were sought via the Veterinary Dermatology discussion list and Veterinary Information Network. Seventeen full-length, peer-reviewed controlled trials reporting clinical outcomes of systemic antimicrobial treatment for canine pyoderma were identified. Outcomes specific to superficial or deep pyoderma were reported in nine and five studies, respectively. Five studies reported outcomes only for nondifferentiated pyoderma depth. Heterogeneity of study designs and outcome measures made meta-analysis inappropriate. A good level of evidence was identified supporting the high efficacy of subcutaneously injected cefovecin in superficial pyoderma and for oral amoxicillin-clavulanic acid in deep pyoderma. A fair level of evidence was identified for moderate to high efficacy of oral amoxicillin-clavulanic acid, clindamycin, cefadroxil, trimethoprim-sulphamethoxazole and sulfadimethoxine-ormetoprim in superficial pyoderma and oral pradofloxacin, oral cefadroxil and subcutaneously injected cefovecin in deep pyoderma. Eleven trials reported observations of adverse effects in treated pyoderma cases by intervention group; four dogs were withdrawn owing to the severity of adverse effects. There is a need for greater numbers of adequately sized, blinded, randomized controlled trials evaluating systemic antimicrobial interventions for canine pyoderma. Improved differentiation between superficial and deep pyoderma in outcome reporting, outcome measure standardization and association of outcomes with causative bacterial species and their resistance patterns are required. © 2012 The Authors. Veterinary Dermatology. © 2012 ESVD and ACVD.
📚延伸阅读
本站内容为养宠科普与用品选购参考，不构成兽医诊疗建议；商品交易最终发生在淘宝，售后、发货咨询请前往淘宝商家。